Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) ... ( NEW YORK May 28 /- Kyowa Hakko U.S.A....)

Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) Citicoline

Date:5/28/2009

NEW YORK, May 28 /PRNewswire/ -- Kyowa Hakko U.S.A., Inc. (Kyowa Hakko USA), the wholly owned subsidiary of Kyowa Hakko Bio Co., Ltd., (Kyowa), has announced it has completed GRAS (Generally Recognized As Safe) self-affirmation for the novel brain health ingredient Cognizin(R) Citicoline.

Cognizin(R) is a branded form of Citicoline, a natural nutrient found in every cell of the body. Citicoline provides an essential nutrient for cells -- particularly brain cells. Cognizin(R) supports brain health in several ways.

First, brain imaging technology has shown that Cognizin(R) helps increase brain energy. * Second, Cognizin(R) provides essential structural components for synthesizing brain cell membranes, which may help facilitate brain cell communication. * Lastly, Cognizin(R) helps support the formation of several brain nutrients that regulate cognitive function. * Cognizin(R) has been the subject of several human clinical trials.

The most recent trial studied the effect of Cognizin(R) on healthy middle-aged adults. Using the latest brain scanning technology, researchers at the Harvard-associated Brain Imaging Center at McLean Hospital in Boston, observed increases in brain activity among people who had taken Cognizin(R) for six weeks, particularly when individuals performed tasks that required sustained attention or memory.

Because Cognizin(R) helps make more energy available to brain cells, they are better able to perform their daily tasks. Cell membranes are synthesized and maintained. Vital brain nutrients are produced and electrical impulses are generated.

These activities may help improve the overall functioning of the brain, which is why Cognizin(R) may significantly increase the ability to focus, concentrate, and make decisions.*

Cognizin(R) Citicoline or CDP-choline will be marketed by Kyowa Hakko USA as a food ingredient in the U
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Astellas Announces New Vice President of Marketing
2. Valeant Announces Increase to Securities Repurchase Program
3. Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoints NextRx Subsidiaries
4. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
5. CenTrak Announces 16 New Deployments This Year: Company Installs Over 6 Million Square Feet in Last Six Months
6. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
7. WellPoint Announces Appearances at Upcoming Conferences
8. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
9. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
10. Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
11. gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStreams Executive Management Team

Post Your Comments:

Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) ...( NEW YORK May 28 /- Kyowa Hakko U.S.A....),Health